The vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology. “An oral COVID-19 vaccine would eliminate several barriers to rapid, wide-scale distribution, potentially enabling people to take the vaccine themselves at home,” Kidron said. Finally, an oral vaccine would not require professional administration. It hopes to also target Africa, where such an oral vaccine could prove essential. In February 2020, shortly after the start of the COVID-19 pandemic, another Israeli team began development on what they hoped would be an oral coronavirus vaccine.
